Onconetix, Inc. SEC filings ONCO
Onconetix, Inc. has 398 filings in SEC EDGAR's recent list, going back to Jul 15, 2019. Its latest annual report, Form ARS, was filed on Oct 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 6, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Sep 8, 2026 | — |
| S-1/A | Amended registration statement | Aug 31, 2026 | — |
| S-1 | Registration statement | Aug 12, 2026 | — |
| 424B3 | Prospectus | Jun 17, 2026 | — |
| S-1 | Registration statement | Jun 9, 2026 | — |
| 424B3 | Prospectus | May 12, 2026 | — |
| S-1/A | Amended registration statement | May 7, 2026 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 | May 7, 2026 | — |
| S-1 | Registration statement | Apr 28, 2026 | — |
| 424B3 | Prospectus | Dec 23, 2025 | — |
| S-1/A | Amended registration statement | Dec 22, 2025 | — |
| 424B3 | Prospectus | Nov 10, 2025 | — |
| S-1 | Registration statement | Nov 4, 2025 | — |
| S-1 | Registration statement | Oct 16, 2025 | — |
| 424B3 | Prospectus | Feb 12, 2025 | — |
| S-1/A | Amended registration statement | Feb 7, 2025 | — |
| S-1 | Registration statement | Jan 27, 2025 | — |
| 424B3 | Prospectus | Dec 17, 2024 | — |
| S-1/A | Amended registration statement | Dec 11, 2024 | — |
| S-8 | Employee stock plan registration | Dec 11, 2024 | — |
| S-1/A | Amended registration statement | Dec 10, 2024 | — |
| 424B4 | Prospectus | Nov 15, 2024 | — |
| S-1/A | Amended registration statement | Nov 12, 2024 | — |
| S-1/A | Amended registration statement | Nov 12, 2024 | — |
| S-1 | Registration statement | Nov 1, 2024 | — |
| S-1 | Registration statement | Nov 1, 2024 | — |
| 424B4 | Prospectus | Jul 3, 2024 | — |
| S-1/A | Amended registration statement | Jun 25, 2024 | — |
| S-1/A | Amended registration statement | Jun 5, 2024 | — |
| S-1/A | Amended registration statement | Apr 26, 2024 | — |
| S-1 | Registration statement | Feb 14, 2024 | — |
| S-8 | Employee stock plan registration | Feb 1, 2024 | — |
| POS AM | Post-effective amendment no. 1 to form s-1 on form s-3 | Apr 28, 2023 | — |
| 424B5 | Prospectus supplement | Mar 29, 2023 | — |
| S-3 | Shelf registration | Mar 9, 2023 | — |
| S-8 | Employee stock plan registration | Nov 14, 2022 | — |
| 424B4 | Prospectus | Sep 20, 2022 | — |
| S-1 | Registration statement | Aug 29, 2022 | — |
| 424B3 | Prospectus | Jun 27, 2022 | — |
| S-8 | Employee stock plan registration | Jun 27, 2022 | — |
| 424B3 | Prospectus | Jun 27, 2022 | — |
| 424B3 | Prospectus | May 23, 2022 | — |
| S-1/A | Amended registration statement | May 19, 2022 | — |
| S-1 | Registration statement | May 3, 2022 | — |
| 424B4 | Prospectus | Feb 23, 2022 | — |
| S-1/A | Amended registration statement | Feb 8, 2022 | — |
| FWP | Free writing prospectus | Jan 21, 2022 | — |
| FWP | Free writing prospectus | Jan 21, 2022 | — |
| S-1/A | Amended registration statement | Jan 6, 2022 | — |
| S-1/A | Amended registration statement | Dec 29, 2021 | — |
| S-1/A | Amended registration statement | Dec 13, 2021 | — |
| S-1/A | Amended registration statement | Nov 29, 2021 | — |
| S-1/A | Amended registration statement | Nov 5, 2021 | — |
| S-1 | Registration statement | Oct 8, 2021 | — |
Showing 54 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ONCO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cincinnati, OH
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1782107
- Former names
- Blue Water Biotech, Inc. (until Dec 18, 2023); Blue Water Vaccines Inc. (until Apr 20, 2023)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.